HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Vestibular neuronitis of inner ear — Clinical Guidelines

Overview

Vestibular neuronitis (VN), also known as acute unilateral vestibulopathy, is an acute condition characterized by sudden-onset unilateral dysfunction of the peripheral vestibular system without involvement of the central nervous system or auditory pathways. Patients typically present with severe vertigo, nausea, vomiting, and postural imbalance, often tilting towards the affected side. This condition significantly disrupts daily activities and diminishes quality of life. Given its prevalence and impact, accurate diagnosis and timely management are crucial in day-to-day clinical practice to alleviate symptoms and restore functional balance 1.

Pathophysiology

The pathophysiology of vestibular neuronitis (VN) is not definitively established but is increasingly linked to inflammatory responses, particularly those triggered by reactivation of herpes simplex virus type 1 (HSV-1). After primary infection, HSV-1 establishes latency in sensory ganglia, including those innervating the inner ear. Periodic reactivation can lead to inflammation within the vestibular nerve, causing damage and dysfunction 1 8. This inflammatory cascade involves various immune cells and mediators such as CD40+ monocytes, macrophages, and increased expression of COX-2 and TNF-α, contributing to neuronal injury and the characteristic symptoms of vertigo and imbalance 1 16. While HSV-1 is a prominent hypothesis, other potential triggers like viral infections or autoimmune mechanisms may also play roles, though evidence remains inconclusive 1 7.

Epidemiology

Vestibular neuronitis has an annual incidence ranging from 3.5 to 15.5 cases per 100,000 individuals, making it a relatively common cause of vertigo 1 2. It predominantly affects adults, with peak incidence observed between the ages of 40 and 50 years, without significant sex predilection 1 5. Geographic and seasonal variations show minimal evidence of seasonality, contradicting some hypotheses linking viral triggers to seasonal patterns 6. Recurrence rates vary, with reports ranging from 1.9% to 10.7%, indicating variability in patient outcomes 6 7. No substantial risk factors beyond age have been consistently identified across studies 1.

Clinical Presentation

Patients with vestibular neuronitis typically present with acute onset of severe vertigo lasting several days, often accompanied by nausea, vomiting, and gait disturbances. Symptoms tend to be unilateral, with a tendency to lean towards the affected side. Additional symptoms may include spontaneous nystagmus, tinnitus, and hearing changes in some cases, though auditory symptoms are usually absent 1 5. Red-flag features include sudden onset of neurological deficits, fever, or signs of central nervous system involvement, which would necessitate further investigation for alternative diagnoses 1.

Diagnosis

The diagnosis of vestibular neuronitis involves a combination of clinical assessment and objective vestibular testing. Key diagnostic criteria include:

Clinical History: Sudden onset of severe vertigo lasting more than 24 hours, without auditory symptoms 1.

Physical Examination: Presence of spontaneous nystagmus, gait and postural instability, and head-shaking nystagmus 1.

Objective Vestibular Testing:

- Caloric Testing: Reduced or absent response on the affected side 1. - Video Head Impulse Test (vHIT): Abnormal gain and saccade accuracy on the affected side 2. - Rotational Chair Testing: Decreased gain and phase asymmetry 1.

Differential Diagnosis:

- Benign Paroxysmal Positional Vertigo (BPPV): Typically triggered by positional changes, with characteristic nystagmus patterns 1. - Ménière’s Disease: Presence of hearing loss, tinnitus, and fluctuating hearing 1. - Central Vestibular Disorders: Neurological signs, MRI abnormalities, or history of stroke 1.

Management

Initial Management

Symptomatic Treatment:

- Antiemetics: Ondansetron 4 mg IV or oral, repeated as needed 1. - Vestibular Sedatives: Promethazine 25 mg orally or IV, consider for severe vertigo 1.

Physical Therapy: Early initiation of vestibular rehabilitation exercises to promote compensation 2.

Long-term Management

Vestibular Rehabilitation Therapy (VRT):

- Gaze Stabilization Exercises: Focus on improving head and eye coordination 2. - Canalith Repositioning Maneuvers: If BPPV is suspected or coexists 1.

Medications:

- Corticosteroids: Consider in cases where inflammation is suspected, e.g., methylprednisolone 24 mg daily for 3 days 1. - Antivirals: Not routinely recommended unless HSV-1 reactivation is strongly suspected 1.

Refractory Cases

Referral to Specialist: Neurotology or otolaryngology specialist for further evaluation and management 1.

Advanced Imaging: MRI to rule out central causes if symptoms persist or worsen 1.

Complications

Persistent Dizziness: Can occur in up to 10.7% of cases, requiring prolonged rehabilitation 6.

Secondary Falls: Increased risk due to postural instability, particularly in the elderly 1.

Psychological Impact: Anxiety and depression may develop secondary to chronic symptoms 1.

Prognosis & Follow-up

The prognosis for vestibular neuronitis is generally good, with most patients recovering within weeks to months. Key prognostic indicators include:

Rapid Initial Recovery: Patients who show early improvement tend to have better outcomes 1.

Age and Severity: Older patients and those with more severe initial symptoms may have slower recovery 1.

Recommended follow-up intervals include:

Initial Follow-up: 1-2 weeks post-onset to assess symptom resolution and need for further therapy 1.

Subsequent Follow-ups: Every 4-6 weeks until symptoms stabilize, then every 3-6 months if symptoms persist 1.

Special Populations

Pediatrics

Vestibular neuronitis in children is rare but can occur, often following upper respiratory tract infections. Diagnosis relies heavily on clinical presentation and vestibular function tests, with management focusing on supportive care and vestibular rehabilitation 5.

Elderly

Elderly patients may experience prolonged recovery and higher risk of secondary complications like falls. Tailored rehabilitation programs and close monitoring are essential 1.

Pregnancy

Limited data exist, but symptomatic management with antiemetics and vestibular rehabilitation should be cautiously employed, avoiding potentially harmful medications 1.

Key Recommendations

Diagnose Based on Clinical Presentation and Objective Testing: Utilize caloric testing and vHIT for confirmation (Evidence: Strong 1).

Initiate Symptomatic Treatment Early: Use antiemetics like ondansetron and consider vestibular sedatives for severe cases (Evidence: Moderate 1).

Early Vestibular Rehabilitation Therapy: Start VRT within the first few weeks to promote compensation (Evidence: Moderate 2).

Consider Corticosteroids in Suspected Inflammatory Cases: Methylprednisolone for 3 days if inflammation is suspected (Evidence: Weak 1).

Monitor for Persistent Symptoms and Complications: Regular follow-ups to assess recovery and manage secondary issues like falls (Evidence: Expert opinion 1).

Refer Complex or Refractory Cases: To neurotology or otolaryngology specialists for further evaluation (Evidence: Expert opinion 1).

Evaluate for Underlying Causes: Consider HSV-1 reactivation in recurrent cases, though routine antiviral therapy is not routinely recommended (Evidence: Moderate 1 7).

Tailor Management for Special Populations: Adjust rehabilitation and monitoring strategies for elderly and pediatric patients (Evidence: Expert opinion 1 5).

Avoid Unnecessary Imaging: MRI reserved for cases with atypical presentations or persistent symptoms (Evidence: Moderate 1).

Provide Psychological Support: Address anxiety and depression in patients with prolonged symptoms (Evidence: Expert opinion 1).

References

1 He Y, Guo T, Dai T, Zhou B, Xie H. Inflammatory proteins and vestibular neuronitis: A Mendelian randomization study. Medicine 2024. link 2 Schubert MC, Migliaccio AA, Della Santina CC. Modification of compensatory saccades after aVOR gain recovery. Journal of vestibular research : equilibrium & orientation 2006. link 3 Cheng Q, Ren A, Han J, Jin X, Pylypenko D, Yu D et al.. Assessment of functional and structural brain abnormalities with resting-state functional MRI in patients with vestibular neuronitis. Acta radiologica (Stockholm, Sweden : 1987) 2023. link 4 Van Hecke R, Van Rompaey V, Wuyts FL, Leyssens L, Maes L. Systemic Aminoglycosides-Induced Vestibulotoxicity in Humans. Ear and hearing 2017. link 5 Dzięciołowska-Baran EA, Gawlikowska-Sroka A. Vertigo with a Vestibular Dysfunction in Children During Respiratory Tract Infections. Advances in experimental medicine and biology 2015. link 6 Koors PD, Thacker LR, Coelho DH. Investigation of seasonal variability of vestibular neuronitis. The Journal of laryngology and otology 2013. link 7 Pollak L, Book M, Smetana Z, Alkin M, Soupayev Z, Mendelson E. Herpes simplex virus type 1 in saliva of patients with vestibular neuronitis: a preliminary study. The neurologist 2011. link 8 Pisonero P, Vallejo L, Menéndez E, Evangelista CR, Alonso A. A clinical study of vestibular neuronitis. Anales otorrinolaringologicos ibero-americanos 1991. link

Vestibular neuronitis of inner ear